// App-Quantinova.ai

e21558 : Does CNS metastases reduce systemic therapy lines for NSCLC patients with EGFR mutation?

Researchers

Presenter

  • Danilo Giffoni

Principal Investigators

  • Maria Luisa Romero

  • Mark Doherty

Medical Centers

  • Sunnybrook Health Sciences Centre, Toronto, ON, Canada

  • Universidad Autonoma de Nuevo Leon, Monterrey, Mexico

  • Department of Medical Oncology, University College Hospital Galway, Galway, Ireland

Locations

  • Canada

  • Mexico

  • Ireland

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Tagrisso

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved